May 10, 2023 / 05:40PM GMT
Travis Lee Steed - BofA Securities, Research Division - MD
Good morning, everybody. Travis Steed, medical device analyst at BofA. And next up, we have Zimmer Biomet. We got the full team up here, Bryan, Suky and Ivan. So thanks for coming, and welcome.
Bryan C. Hanson - Zimmer Biomet Holdings, Inc. - Chairman, President & CEO
Thanks for having us. Great.
Questions and Answers:
Travis Lee Steed - BofA Securities, Research Division - MDI was thinking to break the conversation up kind of 3 pieces. We'll talk kind of Q1, Q2, more near-term trends. And then kind of move to the second bucket, more of the longer-term structural growth drivers for ortho, and how some of that potentially could be structurally different?
And then maybe M&A is kind of the longer-term transition for Zimmer Biomet. So that's how we think about breaking the conversation up. And then so for some of the Q1 stuff, it seems like there was a lot of moving parts in Q1. There was a comp benefit. There was an easier staffing
Trustpilot
